Moodad, S.; El Hajj, R.; Hleihel, R.; Hajjar, L.; Tawil, N.; Karam, M.; Hamie, M.; Abou Merhi, R.; El Sabban, M.; El Hajj, H.
Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma. Cancers 2020, 12, 2483.
https://doi.org/10.3390/cancers12092483
AMA Style
Moodad S, El Hajj R, Hleihel R, Hajjar L, Tawil N, Karam M, Hamie M, Abou Merhi R, El Sabban M, El Hajj H.
Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma. Cancers. 2020; 12(9):2483.
https://doi.org/10.3390/cancers12092483
Chicago/Turabian Style
Moodad, Sara, Rana El Hajj, Rita Hleihel, Layal Hajjar, Nadim Tawil, Martin Karam, Maguy Hamie, Raghida Abou Merhi, Marwan El Sabban, and Hiba El Hajj.
2020. "Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma" Cancers 12, no. 9: 2483.
https://doi.org/10.3390/cancers12092483
APA Style
Moodad, S., El Hajj, R., Hleihel, R., Hajjar, L., Tawil, N., Karam, M., Hamie, M., Abou Merhi, R., El Sabban, M., & El Hajj, H.
(2020). Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma. Cancers, 12(9), 2483.
https://doi.org/10.3390/cancers12092483